Zim Laboratories Ltd (NSE:ZIMLAB)
₹ 124.9 -2.97 (-2.32%) Market Cap: 6.63 Bil Enterprise Value: 7.62 Bil PE Ratio: 104.98 PB Ratio: 2.26 GF Score: 76/100

Q2 2026 ZIM Laboratories Ltd Earnings Call Transcript

Nov 14, 2025 / 05:30AM GMT
Release Date Price: ₹73.99 (+0.71%)
Operator

Ladies and gentlemen, good day, and welcome to ZIM Laboratories Q2 and H1 FY26 earnings conference call hosted by Go India Advisors. (Operator Instructions)

Please note that this conference is being recorded. I now hand the conference over to Ms. Deepika Sharma from Go India Advisors. Thank you, and over to you, ma'am.

Deepika Sharma
Go India Advisors - Analyst

Thank you so much. Good morning, everyone, and welcome to the Q2 and H1 FY26 earnings call of ZIM Laboratories Limited. We have on the call Dr. Anwar Daud, Chairman and Managing Director; Mr. Zulfiquar Kamal, Director, Finance; Mr. Shyam Mohan Patro, Chief Financial Officer; and Mr. Zain Daud, Investor Relations.

We must remind you that the discussion on today's call may include certain forward-looking statements and must be, therefore, viewed in conjunction with the risks that the company faces. May I now request the management to take us through the financials and business outlook, subsequent to which we will open the floor for Q&A.

Thank you, and over to you, sir.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot